Lipella Pharmaceuticals Inc. (LIPO) Financials

LIPO Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2025 2.3 million 862215
June 30, 2025 3.7 million 978534
March 31, 2025 4.9 million 776847
Dec. 31, 2024 2.7 million 754417

LIPO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2025 -2.4 billion ?
June 30, 2025 -1.4 million ?
March 31, 2025 -1.4 million ?
Dec. 31, 2024 -990413 80666

LIPO Net Income

No data available :(

LIPO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2025 1.9 million - 264083
June 30, 2025 2.8 million - 274539
March 31, 2025 4.2 million - 23997
Dec. 31, 2024 2.2 million - 47605

LIPO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2025 4.5 million
June 30, 2025 4.3 million
March 31, 2025 1.0 million
Dec. 31, 2024 1.0 million

LIPO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2025 - 721.0 million 553299 -
June 30, 2025 - 791.6 million 651721 -
March 31, 2025 - 993.5 million 463736 -
Dec. 31, 2024 - 1.1 million 562622 -

LIPO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2025 - 720973
June 30, 2025 86.7 million 791581
March 31, 2025 129.4 million 993475
Dec. 31, 2024 173666 1.1 million

LIPO Revenue by Segment
Graph available only for paid members. Upgrade to see it.

LIPO

Price: $0

52 week price:
0.00
0.64

Earnings Per Share: -2.26 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 2310

Links: